NEW YORK, Dec. 28 /PRNewswire-FirstCall/ -- Immtech Pharmaceuticals, Inc. (Amex: IMM ) will hold an investor conference call on Thursday, January 3, 2008 , at 1 PM (ET ) to present an update on the Company's safety study for pafuramidine, the Company's oral drug candidate.
Lawyer Central Also Recommends These Stories: